Oxidative stress and antioxidants in brain tumors

Therapeutics, Pharmacology and Clinical Toxicology

Volumn 15, Issue 3, 2011, Pages 234-239

  Papacocea, T ^a   Papacocea, R ^b   Badarau A ^b   Ion, A D ^b   Buraga, I ^b   Gaman, L ^b   Papacocea, A ^c  

^a Saint Pantelimon Emergency Hospital   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c NONE   (Romania)

Author keywords

Antioxidant; Glioma; Meningioma; Oxidative stress

Indexed keywords

EID: 84857438472     PISSN: 15830012     EISSN: 20660170     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Papacocea T., Papacocea R, The oxidative stress and blood brain barrier disruption in Alzheimer disease Therapeutics Pharmacology and Clinical Toxicology, 2008 12 (10), pg. 74-78
2. Virgolici B, Mohora M, Stoian I, Lixandru D, Gaman L, Paveliu F A comparative oxidative stress study-obesity with and without diabetes mellitus. Rom J Intern Med, Jan 2005; 43(3-4) pg. 261-8.
3. Rajaraman P, Hutchinson A, Rothman N et al., Oxidative response polymorphisms and risk of adult brain tumors, Neuro-Oncology 2008 10, pg. 709-715
4. Little, M. P., Heidenreich, W. F., Moolgavkar, S. H., Schollnberger, H., and Thomas, D. C. Systems biological and mechanistic modelling of radiation-induced cancer. Radiat Environ Biophys 47, 2008 pg. 39-47
5. Danaila, L Papacocea T, Gheorghitescu L, Radiation - induced Intracranial Meningiomas Romanian Neurosurgery, 1993 1, pg. 57-71
6. Klaunig E, M. Kamendulis LM, Barbara A. Hocevar Oxidative damage in carcinogenesis, Toxicologic Pathology, 2010 38: pg. 96-109
7. Conti A, Guli C, La Torre D, Tomasello C, Angileri F., Aguennouz M H. Role of Inflammation and Oxidative Stress Mediators in Gliomas, Cancers 2010, (2) pg.693-712
8. Cobbs, C.S., Whisenhunt, T.R.; Wesemann, D.R.; Harkins, L.E.; Van Meir E.G.; Samanta, M. Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res. 2003, (63) pg.8670-8673
9. Rao GM, Rao AV, Raja A, Rao S, Rao A. Role of antioxidant enzymes in brain tumours. Clin Chim Acta. 2000 (296) pg.203-212
10. Arthur, J. R. The glutathione peroxidases. Cell Mol Life Sci, 2000 (57) pg1825-35
11. Bhatti P, Stewart P, Hutchinson A, Lead Exposure, Polymorphisms in Genes Related to Oxidative Stress, and Risk of Adult Brain Tumors Cancer Epidemiol Biomarkers Prev 2009;18:1841-1848
12. Papacocea T. Roşca T, Bǎdǎrǎu A., Papacocea R., Ciornei C., Ion A.D. -, Cystic meningioma - case report Chirurgia, 2009 104(1), pg. 99-103
13. Ezer R, Alonso M, Pereira E, et al. Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neurooncol. 2002 Sep;59(2):123-34.
14. Gilca M, Stoian I, Lixandru D, Gaman L, Virgolici B, Atanasiu V. Protection of erythrocyte membrane against oxidative damage by geriforte in healthy human subjects. Rom J Intern Med, Jan 2009; 47(3): 289-95
15. Forsberg, L., Lyrenas, L., de Faire, U., Morgenstern, R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001 30, pg.500-5
16. Angileri, F.F.; Aguennouz, M.; Conti, A et al. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Cancer 2008 112 pg.2258-2266
17. Papacocea A, Papacocea T, Dǎnǎilǎ L, Papacocea R, Ion D, Bǎdǎrǎu A,. Primary intracerebellar hematomas: surgical indications, prognosis. Chirurgia. 2010 105(6) pg 805-7.
18. Papacocea T, Papacocea A, Dǎnǎilǎ L et al. Posterior fossa epidural Chirurgia. 2011 106(3) pg 309-313
19. Zengin E, Atukeren P, Kokoglu E, Gumustas MK, Zengin U. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues. Clin Neurol Neurosurg. 2009 111(4) pg.345-51
20. Marklund S: Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 1984. 74 pg.1398-1403
21. Papacocea T, Papacocea R, Badarau A et al. The oxidative stress impact on brain aging, Therapeutics Pharmacology and Clinical Toxicology, 2008, 12 (2) pg. 215-222
22. Keir ST, Dewhirst MW, Kirkpatrick JP, Bigner DD, Batinic-Haberle I. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTn-Hex-2-PyP(5+) in the treatment of brain tumors. Anticancer Agents Med Chem. 2011 11(2) pg 202-12.
23. Ma Y, Chen H, Xia W, Ying W. Oxidative stress and PARP activation mediate the NADH induced decrease in glioma cell survival Int J Physiol Pathophysiol Pharmacol 2011;3(1) pg 21-28)
24. Ma Y, Chen H, Zhao C, Xia W, Ying W. NADPH treatment decreases C6 glioma cell survival by increasing oxidative stress. Front Biosci (Elite Ed). 2011 Jun 1;3:1221-8
25. Kavanagh, R. J. Kam, P. C. (2001). Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection. Br. J. Anaesth. 86 pg 110-119
26. Joki, T.; Heese, O.; Nikas, D.C. et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res. 2000, 60 pg 4926-4931
27. Wagemakers, M.; van der Wal, G.E.; Cuberes, R et al. COX-2 Inhibition Combined with Radiation Reduces Orthotopic Glioma Outgrowth by Targeting the Tumor Vasculature. Transl. Oncol. 2009, 2, pg 1-7
28. Das UN .Gamma-linolenic acid therapy of human gliomaa review of in vitro, in vivo, and clinical studies. Med Sci Monit. 2007 13(7) pg 119-31
29. Dayani PN, Bishop MC, Black K, Zeltzer PM. Desferoxamine (DFO)-mediated iron chelation: rationale for a novel approach to therapy for brain cancer. J Neurooncol. 2004 67(3) pg. 367-377
30. Toyokuni S. Iron as a target of chemoprevention for longevity in humans. Free Radic Res. 2011 45(8) pg 906-17
31. Kang, Y. H., Lee, E., Choi, M. K et al. Role of reactive oxygen species in the induction of apoptosis by alphatocopheryl succinate. Int J Cancer 2004 112, pg.385-392
32. Aggarwal S, Subberwal M, Sharma M., Brain tumor and role of β-carotene, α- tocopherol, superoxide dismutase and glutathione peroxidase J Cancer Res Ther - 2006 2 (1), pg. 24-27
33. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 2000 23 pg. 209-216
34. Levenson CW, Figueiroa SM. Gestational vitamin D deficiency: long-term effects on the brain. Nutr Rev. 2008 66(12):726-9.
35. Elias J, Marian B, Edling C et al. Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res. 2003;164 pg.319-32.
36. van Ginkel PR, Yang W, Marcet MM, Chow CC, Kulkarni AD, Darjatmoko S, et al. 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol. 2007;85(3) pg.255-262
37. Il'yasova D, Marcello J, McCoy L, Rice T, Wrensch M. Total dietary antioxidant index and survival in patients with glioblastoma multiforme, Cancer Causes and Control, 2011 22 (8) pg 1255-1260
38. Gao Z, Xu MS, Barnett TL, Xu CW. Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochem Biophys Res Commun. 2011 407(2) pg 271-6
39. Leone S, Fiore M, Lauro MG, Pino S, Cornetta T, Cozzi R. Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells. MolCarcinog. 2008 47(8) pg.587-598
40. Gagliano N, Aldini G, Colombo G, Rossi R, Colombo R, Gioia M, et al. The potential of resveratrol against human gliomas. Anticancer Drugs. 2010 21(2) pg.140-150
41. Zamin LL, Filippi-Chiela EC, Dillenburg-Pilla P, Horn F, Salbego C, Lenz G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci. 2009 100(9) pg 1655-62)
42. Braganhol E, Zamin LL, Canedo AD, et al. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs. 2006 17(6) pg 663-671
43. Siegelin MD, Reuss DE, Habel A, Rami A, von Deimling A. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. NeuroOncol. 2009 11(2) pg.122-131
44. Han DH, Lee MJ. Kim JH. Antioxidant and Apoptosisinducing Activities of Ellagic Acid Anticancer Research 2006 26: pg 3601-3606
45. Ajith TA, Ameliorating reactive oxygen species-induced in vitro lipid peroxidation In brain, liver, mitochondria and DNA damage by zingiber officinale Roscoe Indian Journal of Clinical Biochemistry, 2010 25 (1) pg 67-73
46. Gilca M, Gaman L, Panait E, Stoian I, Atanasiu V. Chelidonium majus-an integrative review: traditional knowledge versus modern findings. Forsch Komplementmed, Oct 2010; 17(5): 241-8.
47. Wion D, Berger F, Wion-Barbot N. Glioma, melatonin, and radiotherapy. Cancer Res. 2006 Jun 15;66(12):6457.